The Patent Finder

Terms ending in 2043

Amgen Inc.

Every in-force patent on Amgen Inc.'s record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,702,761Lockout Mechanism for Drug Delivery Device
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,128,593Manufacturing Process for Hollow Plunger Rod
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,427,241Systems and Methods for Drug Delivery
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,723,047Heterocyclic Spiro Compounds and Methods of Use
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,552,808Diol Desymmetrization by Nucleophilic Aromatic Substitution
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,480,858Automated Visual Inspection
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,729,229ENGINEERED NRG-1 VARIANTS WITH IMPROVED SELECTIVITY TOWARD ErbB4 BUT NOT AGAINST ErbB3
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,643,913MCL-1 Inhibitor Formulations
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,728,199Needle Insertion Mechanism for Drug Delivery Device
In force
 · High confidence
Amgen Inc.In forceHigh confidence
US 12,194,039Methods of Treating Heart Failure by Administering Omecamtiv Mecarbil
In force
 · High confidence
Amgen Inc.In forceHigh confidence
43 more term ends in 2043 · Pro
10 of 53 patents shown. Soonest term end first, then patent number.
Pro members see all 53.
Upgrade to Pro
49 of these are in force and held by Amgen Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited